COMPOSITION GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta-4): 10 mg Appearance: Lyophilized powder in a sealed research vial RESEARCH FOCUS (NON-CLINICAL) Combined evaluation of copper peptide, BPC-157, and TB-500 in laboratory model systems Analytical assay development and validation for multi-peptide formulations Chromatographic method optimization for separation and impurity profiling Stability characterization of multi-component lyophilized peptide blends under laboratory storage conditions Identity and purity assessment using validated analytical methods DOCUMENTATION Lot-specific Certificate of Analysis (COA) Batch and lot traceability QR code access to product documentation Manufacturing quality documentation IMPORTANT NOTICE For research use only Not for human consumption Not intended for diagnostic, therapeutic, veterinary, or clinical use Not intended to diagnose, treat, cure, or prevent any disease QUALITY & MANUFACTURING Manufactured in the USA in an ISO 9001-based, cGMP-aligned facility Third-party tested with lot-specific Certificate of Analysis (COA) Lyophilized for laboratory stability and secure transit Tamper-evident seal with printed lot number and test date Each lot documented throughout production

She also suffered cardiac arrest while still recovering from surgery in the hospital
Unlocking Long-Term Patient Retention: How Sofwave Bridges the Gap for the GLP-1 Generation Date Written by CJ Sander Revised by Johnny Franco, MD Sofwave ultrasound treatment serves as a strategic "bridge" for aesthetic practices, helping convert GLP-1 weight-loss patients into long-term retention successes
If You Have Insurance Contact your insurance provider before filling a prescription